Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | ATPase family, AAA domain containing 5 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | Get druggable targets OG5_139225 | All targets in OG5_139225 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0016 | 0.0066 | 1 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0016 | 0.0066 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0349 | 1 |
Echinococcus multilocularis | GPCR, family 2 | 0.0108 | 0.1018 | 0.1018 |
Schistosoma mansoni | tar DNA-binding protein | 0.0519 | 0.5249 | 1 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0108 | 0.1018 | 0.194 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0349 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0519 | 0.5249 | 1 |
Brugia malayi | RNA binding protein | 0.0519 | 0.5249 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0132 | 0.1263 | 0.231 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0016 | 0.0066 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.0349 | 0.0349 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0349 | 1 |
Giardia lamblia | Replication factor C, subunit 1 | 0.001 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0016 | 0.0066 | 0.5 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0016 | 0.0066 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0108 | 0.1018 | 0.1837 |
Schistosoma mansoni | hypothetical protein | 0.0234 | 0.2315 | 0.441 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0016 | 0.0066 | 0.5 |
Brugia malayi | TAR-binding protein | 0.0519 | 0.5249 | 1 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0108 | 0.1018 | 0.1837 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0349 | 0.0666 |
Schistosoma mansoni | hypothetical protein | 0.0108 | 0.1018 | 0.194 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0016 | 0.0066 | 0.0126 |
Loa Loa (eye worm) | hypothetical protein | 0.0234 | 0.2315 | 0.4339 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0108 | 0.1018 | 0.1837 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0108 | 0.1018 | 0.194 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0108 | 0.1018 | 0.1018 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0342 | 0.3432 | 0.6494 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0342 | 0.3432 | 0.6494 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0016 | 0.0066 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.0349 | 0.0666 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0066 | 0.0066 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0016 | 0.0066 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.0349 | 0.0666 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0519 | 0.5249 | 1 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0066 | 0.0066 |
Schistosoma mansoni | tar DNA-binding protein | 0.0519 | 0.5249 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0342 | 0.3432 | 0.6494 |
Echinococcus granulosus | tar DNA binding protein | 0.0519 | 0.5249 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0108 | 0.1018 | 0.194 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0519 | 0.5249 | 1 |
Echinococcus multilocularis | geminin | 0.0205 | 0.2012 | 0.2012 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0016 | 0.0066 | 0.0066 |
Brugia malayi | MH2 domain containing protein | 0.0132 | 0.1263 | 0.231 |
Echinococcus granulosus | geminin | 0.0205 | 0.2012 | 0.3832 |
Loa Loa (eye worm) | TAR-binding protein | 0.0519 | 0.5249 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0519 | 0.5249 | 1 |
Trichomonas vaginalis | replication factor C large subunit, putative | 0.001 | 0 | 0.5 |
Trichomonas vaginalis | chromosome transmission fidelity factor, putative | 0.001 | 0 | 0.5 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0016 | 0.0066 | 0.0066 |
Trichomonas vaginalis | chromosome transmission fidelity factor, putative | 0.001 | 0 | 0.5 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0016 | 0.0066 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0108 | 0.1018 | 0.194 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0342 | 0.3432 | 0.6494 |
Schistosoma mansoni | tar DNA-binding protein | 0.0519 | 0.5249 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0108 | 0.1018 | 0.194 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.2012 | 0.3832 |
Echinococcus granulosus | GPCR family 2 | 0.0108 | 0.1018 | 0.194 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0349 | 1 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0066 | 0.0126 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0066 | 0.0066 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0016 | 0.0066 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.2012 | 0.3832 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0132 | 0.1263 | 0.231 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0108 | 0.1018 | 0.1018 |
Echinococcus multilocularis | tar DNA binding protein | 0.0519 | 0.5249 | 0.5249 |
Brugia malayi | hypothetical protein | 0.0043 | 0.0349 | 0.0546 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0108 | 0.1018 | 0.1837 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0234 | 0.2315 | 0.4339 |
Loa Loa (eye worm) | RNA binding protein | 0.0519 | 0.5249 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.2593 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 14.7157 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 16.3601 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 18.3489 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 37.933 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.